Rocket Pharmaceuticals
RCKT
RCKT
81 hedge funds and large institutions have $751M invested in Rocket Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
7% less funds holding
Funds holding: 87 → 81 (-6)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
81
Holding in Top 10
2
Calls
$2.63M
Puts
$2.48M
Top Buyers
| 1 | +$8.26M | |
| 2 | +$6.93M | |
| 3 | +$5.98M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.79M |
| 5 |
Morgan Stanley
New York
|
+$4.54M |
Top Sellers
| 1 | -$8.77M | |
| 2 | -$6.07M | |
| 3 | -$5.98M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.31M |
| 5 |
BM
Bridger Management
New York
|
-$3.93M |